黃仁勳密集亞洲之旅 公佈四國合作或投資計劃
據《澎湃新聞》報道,英偉達(NVDA.US)CEO黃仁勳的亞洲之行收穫豐富,先後公佈了在日本、新加坡、馬來西亞和越南四國的合作或投資計劃,表現出公司對亞洲市場的重視。
當地時間12月10日,越南政府網站發文稱,總理範明政當日與黃仁勳會面。黃仁勳表示,英偉達「將越南視爲自己家」,公司希望在越南建立一個半導體基地,因爲越南是一個重要的市場。越南政府表示,該基地將吸引來自世界各地的人才,爲越南半導體生態系統和數位化的發展作出貢獻。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.